Clevidipine Nitroso
Specifications
Product name
Clevidipine Nitroso
SRC CAT No
SRC-N014477
CAS No
NA
Mol.F.
C21H22Cl2N2O7
Mol.Wt.
485.31 g/mol
Related CAS No.
NA
Inv Status
CUSTOM SYNTHESIS
Chemical Structure
Product Overview
Description
Chemical Name
3-((Butyryloxy)methyl)5-methyl4-(2,3-dichlorophenyl)-2,6-dimethyl-1-nitroso-1,4-dihydropyridine-3,5-dicarboxylate
HSN Code
38229010
Synonym
N.A
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Clevidipine is a potent arterial vasodilator whose primary use is as a parenteral antihypertensive agent.Clevidipine Nitroso is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Clevidipine Nitroso CAS NO:NA chemically represented as 3-((Butyryloxy)methyl)5-methyl4-(2,3-dichlorophenyl)-2,6-dimethyl-1-nitroso-1,4-dihydropyridine-3,5-dicarboxylate.Synchemia is the leading manufacturing and exporter of Clevidipine Nitroso . We supply Clevidipine Nitroso with detailed characterization data compliance with regulatory guidelines."
Make an Enquiry for Abacavir EP Impurity A
Share your requirement and our team will take it forward with
clarity, confidentiality, and technical precision.
Related Products
Succinylcholine Nitroso Impurity 2
| CAT No | SRC-N0143640 |
| CAS No | NA |
| Mol.F. | C7H12N2O5 |
| Mol.Wt. | 204.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
2-(dimethylamino)ethyl (2-(methyl(nitroso)amino)ethyl) succinate
| CAT No | SRC-N0143641 |
| CAS No | NA |
| Mol.F. | C11H21N3O5 |
| Mol.Wt. | 275.31 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Tafenoquine
| CAT No | SRC-N0143642 |
| CAS No | NA |
| Mol.F. | C24H27F3N4O4 |
| Mol.Wt. | 492.50 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
Lasmiditan Nitroso Impurity 1
| CAT No | SRC-N0143643 |
| CAS No | NA |
| Mol.F. | C11H14N4O2 |
| Mol.Wt. | 234.26 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
Lasmiditan Nitroso Impurity 2
| CAT No | SRC-N0143644 |
| CAS No | NA |
| Mol.F. | C18H15F3N4O3 |
| Mol.Wt. | 392.33 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Oxetacaine Stage D | N-methyl-N-(2-methyl-1-phenylpropan-2-yl)nitrous amide
| CAT No | SRC-N0143645 |
| CAS No | NA |
| Mol.F. | C11H16N2O3 |
| Mol.Wt. | 192.26 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Oxatomide
| CAT No | SRC-N0143646 |
| CAS No | NA |
| Mol.F. | C27H29N5O2 |
| Mol.Wt. | 455.56 g/mole |
| INV STATUS | UNDER SYNTHESIS |
N-Nitroso Oxatomide N-Oxide
| CAT No | SRC-N0143647 |
| CAS No | NA |
| Mol.F. | C2729N5O3 |
| Mol.Wt. | 471.56 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
Cinnarizine Nitroso Impurity 1
| CAT No | SRC-N0143648 |
| CAS No | NA |
| Mol.F. | C14H19N5O2 |
| Mol.Wt. | 289.3 g/mole |
| INV STATUS | UNDER SYNTHESIS |
Tivozanib Nitroso Impurity 1
| CAT No | SRC-N0143649 |
| CAS No | NA |
| Mol.F. | C28H23ClN4O6 |
| Mol.Wt. | 547 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
Fezolinetant Niroso Impurity 1
| CAT No | SRC-N0143650 |
| CAS No | NA |
| Mol.F. | C9H11N7OS |
| Mol.Wt. | 265.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
Fezolinetant Niroso Impurity 2
| CAT No | SRC-N0143651 |
| CAS No | NA |
| Mol.F. | C5H9N3O2 |
| Mol.Wt. | 143.1 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |